{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:58:55Z","timestamp":1761562735015,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Hospital de Cl\u00ednicas de Porto Alegre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clnu.2021.01.022","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T07:53:38Z","timestamp":1611734018000},"page":"4275-4283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6048-2748","authenticated-orcid":false,"given":"Vittoria Zambon","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valesca","family":"Dall\u2019Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clnu.2021.01.022_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/ceh.2018.78120","article-title":"A systematic review of the present and future of non-alcoholic fatty liver disease","volume":"4","author":"Lucas","year":"2018","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2021.01.022_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"issue":"24","key":"10.1016\/j.clnu.2021.01.022_bib3","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.4254\/wjh.v7.i24.2522","article-title":"Dietary approach in the treatment of nonalcoholic fatty liver disease","volume":"7","author":"Ferolla","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2021.01.022_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MEG.0000000000001279","article-title":"Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?","volume":"31","author":"Softic","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2021.01.022_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2017.12.001","article-title":"A critical review of endpoints for non-cirrhotic NASH therapeutic trials","volume":"68","author":"Ratziu","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.clnu.2021.01.022_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"issue":"9","key":"10.1016\/j.clnu.2021.01.022_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/nu9090981","article-title":"Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease","volume":"9","author":"Ter Horst","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnu.2021.01.022_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00019.2009","article-title":"Metabolic effects of fructose and the worldwide increase in obesity","volume":"90","author":"Tappy","year":"2010","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.clnu.2021.01.022_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/nu10030295","article-title":"Use of table sugar and artificial sweeteners in Brazil: national dietary Survey 2008\u20132009","volume":"10","author":"Silva Monteiro","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnu.2021.01.022_bib10","first-page":"109","article-title":"Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction","volume":"4","author":"Basaranoglu","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.clnu.2021.01.022_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of nonalcoholic fatty liver disease","author":"Jensen","year":"2018","journal-title":"J\u00a0Hepatol"},{"year":"1985","series-title":"Energy and protein requirements. Report of a join FAO\/WHO\/UNU expert consultation","key":"10.1016\/j.clnu.2021.01.022_bib12"},{"key":"10.1016\/j.clnu.2021.01.022_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-018-0347-0","article-title":"Optimal cut-off points for waist circumference in the definition of metabolic syndrome in Brazilian adults: baseline analyses of the Longitudinal Study of Adult Health (ELSA-Brasil)","author":"Cardinal","year":"2018","journal-title":"Diabetol Metab Syndrome"},{"issue":"1","key":"10.1016\/j.clnu.2021.01.022_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0095-4543(21)00452-8","article-title":"Screening for nutritional status in the elderly","volume":"21","author":"Lipschitz","year":"1994","journal-title":"Prim Care"},{"key":"10.1016\/j.clnu.2021.01.022_bib15","doi-asserted-by":"crossref","DOI":"10.1590\/S1415-52732008000200009","article-title":"A\u00a0dinamometria manual e seu uso na avalia\u00e7\u00e3o nutricional","author":"Schlussel","year":"2008","journal-title":"Rev Nutr"},{"key":"10.1016\/j.clnu.2021.01.022_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glu023","article-title":"Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness","author":"Cawthon","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.clnu.2021.01.022_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.clnu.2021.01.022_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2021.01.022_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","author":"Guerrero-Romero","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"20","key":"10.1016\/j.clnu.2021.01.022_bib20","first-page":"2835","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels","volume":"256","author":"Castelli","year":"1986","journal-title":"The Framingham Study \u2013 JAMA"},{"key":"10.1016\/j.clnu.2021.01.022_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.clnu.2021.01.022_bib22","article-title":"Antropometria na avalia\u00e7\u00e3o da obesidade abdominal e risco coronariano","author":"Pitanga","year":"2011","journal-title":"Rev Bras Cineantropom Desempenho Hum"},{"journal-title":"Circulation","year":"2009","author":"Alberti","key":"10.1016\/j.clnu.2021.01.022_bib23"},{"issue":"2 Suppl. 1","key":"10.1016\/j.clnu.2021.01.022_bib24","first-page":"1","article-title":"Atualiza\u00e7\u00e3o da Diretriz Brasileira de Dislipidemias e Preven\u00e7\u00e3o da Aterosclerose","volume":"109","author":"Sociedade Brasileira de Cardiologia","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.clnu.2021.01.022_bib25","doi-asserted-by":"crossref","DOI":"10.1590\/S0047-20852012000300001","article-title":"Alcohol use disorder identification test (AUDIT): explorando seus par\u00e2metros psicom\u00e9tricos","author":"Santos","year":"2012","journal-title":"J\u00a0Bras Psiquiatr"},{"key":"10.1016\/j.clnu.2021.01.022_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2016.3","article-title":"Management of NAFLD: a stage-based approach","author":"Rinella","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.01.022_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2021.01.022_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/j.1478-3231.2009.02192.x","article-title":"Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients","author":"Kim","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2021.01.022_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.aje.a114366","article-title":"Total energy intake: implications for epidemiologic analyses","author":"Willett","year":"1986","journal-title":"Am J Epidemiol"},{"year":"2010","series-title":"Australian Food Composition Database, nutrient tables for use in Australia","author":"Food","key":"10.1016\/j.clnu.2021.01.022_bib31"},{"year":"2011","series-title":"Pesquisas em alimenta\u00e7\u00e3o \u2013 NEPA\/UNICAMP. Tabela brasileira de Composi\u00e7\u00e3o de Alimentos (TACO)","author":"N\u00facleo de Estudos","key":"10.1016\/j.clnu.2021.01.022_bib32"},{"year":"2011","series-title":"Tabela de composi\u00e7\u00e3o nutricional dos alimentos consumidos no Brasil (IBGE)","author":"da Sa\u00fade","key":"10.1016\/j.clnu.2021.01.022_bib33"},{"year":"2016","series-title":"NOVA. A estrela brilha","author":"Monteiro","key":"10.1016\/j.clnu.2021.01.022_bib34"},{"key":"10.1016\/j.clnu.2021.01.022_bib35","series-title":"CRC handbook of dietary fiber in human nutrition","article-title":"Dietary fiber values for common foods","author":"Schakel","year":"2001"},{"year":"2013","series-title":"Nutritional epidemiology","author":"Willet","key":"10.1016\/j.clnu.2021.01.022_bib36"},{"year":"2005","series-title":"Dietary reference intakes (DRI's) for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients)","key":"10.1016\/j.clnu.2021.01.022_bib37"},{"key":"10.1016\/j.clnu.2021.01.022_bib38","article-title":"Sarcopenic obesity in fatty liver","author":"Merli","year":"2019","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2021.01.022_bib39","article-title":"Vitamin D and related deficiencies, sarcopenia and visceral obesity in obese people with NAFLD","author":"Nikolova","year":"2018","journal-title":"Gastroenterol Hepatol Open Access"},{"key":"10.1016\/j.clnu.2021.01.022_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ejcn.2017.148","article-title":"Associations between dietary factors and markers of NAFLD in a general Dutch adult population","author":"Rietman","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.01.022_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1957","article-title":"Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study","author":"Etemadi","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2021.01.022_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.01.015","article-title":"High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance","author":"Zelber-Sagi","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ncp.10393","article-title":"A\u00a0systematic review of medical nutrition therapy guidelines for liver cirrhosis: do we agree?","author":"Theodoridis","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2021.01.022_bib44","article-title":"Nutritional challenges in patients with advanced liver cirrhosis","author":"Stirnimann","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnu.2021.01.022_bib45","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v24.i30.3330","article-title":"Nutritional issues in patients with obesity and cirrhosis","author":"Schiavo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2021.01.022_bib46","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2017.0103","article-title":"NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs","author":"Caldwell","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib47","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v7.i25.2597","article-title":"Dietary supplements and pediatric non-alcoholic fatty liver disease: present and the future","author":"Rahimlou","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib48","article-title":"A\u00a0New dietary inflammatory index predicts interval changes in serum high-sensitivity","author":"Protein","year":"2009","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.clnu.2021.01.022_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000000776","article-title":"Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis","author":"Wijarnpreecha","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib50","article-title":"Recent advances on Ilex paraguariensis research: minireview","author":"Gugliucci","year":"2010","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.clnu.2021.01.022_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","author":"Ouyang","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib52","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.30121","article-title":"Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates","author":"Ullah","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.clnu.2021.01.022_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","author":"Volynets","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2021.01.022_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/ejcn.2014.8","article-title":"Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials","author":"Chiu","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2021.01.022_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/nu10080981","article-title":"Sugar-sweetened soft drinks and fructose consumption are associated with hyperuricemia: cross-sectional analysis from the Brazilian longitudinal study of adult health (ELSA-Brasil)","author":"Siqueira","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2021.01.022_bib56","doi-asserted-by":"crossref","DOI":"10.1139\/apnm-2012-0322","article-title":"Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles","author":"Bravo","year":"2013","journal-title":"Appl Physiol Nutr Metabol"},{"key":"10.1016\/j.clnu.2021.01.022_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2013.07.037","article-title":"Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients","author":"Petta","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2021.01.022_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-315940","article-title":"Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study","author":"Alferink","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.01.022_bib59","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.114.086074","article-title":"Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults","author":"Kanerva","year":"2014","journal-title":"Am J Clin Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:04:10Z","timestamp":1759367050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561421000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0261561421000467"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2021.01.022","relation":{},"ISSN":["0261-5614"],"issn-type":[{"type":"print","value":"0261-5614"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2021.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}